Bei Naga Markets registrieren
Qiagen, NL0015002SN0

Qiagen stock ahead of the Xetra open with closing price EUR 40.75 on October 13, 2026

Published on 10/14/2026 at 07:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Qiagen stock was last quoted at EUR 40.75 at Lang & Schwarz on October 13, 2026. QIAGEN recently expanded its U.S. bloodstream-infection testing portfolio.

Testing portfolio expansion

  • Qiagen stock was last quoted at EUR 40.75 at Lang & Schwarz on October 13, 2026.
  • The next Xetra session is scheduled for October 14, 2026.
  • QIAGEN's September 28, 2026 announcement covered 33 pathogen targets and 28 antibiotic resistance markers.
Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht
Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

On October 13, 2026, Qiagen stock had a closing indication of EUR 40.75 at Lang & Schwarz ahead of the October 14 Xetra session.

Price ahead of the Xetra open

The latest closing indication was EUR 40.75. The first price of the day is shown from the start of trading by the continuously updated real-time quote of Qiagen stock.

U.S. diagnostic portfolio expanded

In a September 28, 2026 release, QIAGEN said U.S. laboratories had access to its complete QIAstat-Dx bloodstream-infection portfolio after FDA clearance of a new panel. The company said the new panel identifies 13 gram-negative bacterial targets and 18 antibiotic-resistance markers in about one hour. Together, the two panels cover 33 pathogen targets and 28 antibiotic-resistance markers.

Market context: Market report AEX.

More news and analysis on Qiagen stock

Disclaimer...

en | NL0015002SN0 | QIAGEN | boerse | 70320072 | bgmi